Limitations
medulloblastoma
MEDULLOBLASTOMA
There are some important limitations of our study. The patient population reported in this trial, although all having relapsed medulloblastoma after standard up-front surgery, radiation therapy, and chemotherapy, is heterogeneous with regard to their molecular subgrouping, and the study was underpowered to detect true differences between groups. In contrast to a previous publication,